The 20th-century theory of mammalian sex determination states that the embryo is sexually indifferent until the differentiation of gonads, after which sex differences in phenotype are caused by the differential effects of gonadal hormones. However, this theory is inadequate because some sex differences precede differentiation of the gonads and/or are determined by non-gonadal effects of the sexual inequality in the number and type of sex chromosomes. In this article, I propose a general theory of sex determination, which recognizes multiple parallel primary sex-determining pathways initiated by genes or factors encoded by the sex chromosomes. The separate sex-specific pathways interact to synergize with or antagonize each other, enhancing or reducing sex differences in phenotype.
A general theory of mammalian sex determination The theory of mammalian sex determination was recently stated as follows: 'the sexual phenotype of individuals is dependent on the gonad: male and female somatic cells and tissues are initially sexually indifferent and sexual dimorphism is imposed by the type of gonad that develops' [1] . This theory was developed during the 20th century and was based on experiments in which the 'sex of the individual' was defined by a limited group of phenotypes, predominantly the gonads and genitalia. Because sexual differentiation of the gonads was placed at the center of the sex determination universe, the foremost task in understanding sex determination was to discover the sexspecific factors that cause undifferentiated gonadal primordia to develop differently in the two sexes. The first sex-specific event in the molecular cascade leading to the divergent development of the gonads in the two sexes is the expression of the Y chromosome gene Sry (see Glossary) in the undifferentiated gonadal ridge of the male [2] . Sry promotes testicular development and suppresses ovarian differentiation, whereas autosomal or X genes in females initiate ovarian development and suppress testicular development [3, 4] . Once the gonads differentiate, however, they secrete gonadal hormones that cause sex-specific patterns of development in many other tissues, such as the external genitalia, internal genitalia (Wolffian and Mü llerian duct structures) and brain. Although there is little controversy regarding the importance of gonadal secretions in sex determination of non-gonadal tissues, evidence from the past 20 years or so indicates that the theory as stated in the first sentence is incorrect.
The theory suffers on several counts: (i) it is based on an unacceptably narrow definition of sex; (ii) it incorrectly suggests that gonadal determination precedes all other sex differences; (iii) it misses other X and Y genes that have a logically equal position to Sry as primary sex-biased gene products; and (iv) importantly, it does not explain a growing list of sex differences in phenotype that are not controlled by the gonads and, therefore, are not downstream of differences initiated by Sry. Thus, in constructing a more accurate general theory of sex determination, gonadal differentiation should be displaced as the central event of sex determination and replaced with whatever other condition is the unitary origin of all sex differences.
In animals with heteromorphic sex chromosomes, all sex differences stem from the inherent sexual inequality of the sex chromosomes (X and Y in mammals), which are the only factors known to differ consistently in male and female zygotes. Here, I summarize evidence that numerous X and Y chromosomal factors, not just Sry, are primary in determining the sex of tissues in mammals. This diverse set of primary sex-determining genes and their downstream products, such as gonadal hormones, interact with each other to produce female and male animals with sextypical phenotypes that, in combination, define the sex of the individual.
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Glossary
Heteromorphic sex chromosomes: sex chromosomes that differ in gene content. Mü llerian ducts: embryonic structures found in both sexes but that in females differentiate into oviduct, uterus and upper vagina. Sf1: (steroidogenic factor 1, NR5A1). Sf1 is expressed in gonads, adrenals, brain and pituitary, and is required for the development and function of each. Mice lacking Sf1 never develop gonads or adrenals. Sry: (sex-determining region Y). Sry is a Y chromosome gene that initiates differentiation of testes in males. Wolffian ducts: embryonic structures found in both sexes that in males differentiate into the sperm ducts (epididymis and vas deferens) and seminal vesicles. X-inactivation: transcriptional silencing of one of the two X chromosomes in each XX female non-germline cell. Xist: (X inactivation-specific transcript). In mammalian cells with two X chromosomes, the X inactivation center encodes factors that count the number of X chromosomes and trigger expression of Xist from one X chromosome. Xist causes transcriptional silencing (inactivation) of the chromosome from which it is expressed. Corresponding author: Arnold, A.P. (arnold@ucla.edu).
Limits of the 20th-century theory: why the gonads are primary and why they are not Although the sex of the individual can be defined in many ways and assessed based on the measurement of an almost unlimited number of phenotypes, from gonadal type to personality, historically gonadal differentiation was reasonably considered the premier event of mammalian sex determination (Box 1). First, the differentiation of two types of gamete is at the crux of the evolution of sexual reproduction and, thus, the gamete-producing tissues (gonads) and tissues involved in gamete delivery and reproduction (genitalia and brain) are fundamental to the definition of the sex of an individual. Second, the genetic control of the sex of the gonads was seen as mechanistically distinct from, and the developmental antecedent of, the sexual differentiation of other tissues. Gonadal differentiation was viewed as genetic, caused by factors inherent to the XX versus XY difference in the genome, whereas non-gonadal sexual differentiation was hormonal, driven by secretions of the gonads. For example, masculine differentiation occurred in XX or XY individuals as long as male hormones were present. Both historical and modern data support the idea that most sex differences in non-gonadal tissues are caused by gonadal secretions [5, 6] . However, beginning before 1990 and with greater frequency since then, the sexual phenotype of specific cells or tissues has been repeatedly shown to also be influenced by sex chromosome complement (XX versus XY) factors that are not downstream of gonadal hormones. It is not desirable to retain the old theory along with a rapidly growing list of inconvenient footnotes that document where the old theory fails, but rather to articulate a new framework that accounts for all experimental results. A new perspective, proposed here, recognizes a set of primary sex-determining factors encoded by the sex chromosomes, which are all the result of the original zygotic imbalance in the number of X and Y chromosomes. This imbalance leads to numerous inescapable sex differences in X and Y gene expression that are all primary in the causation of sex differences in tissues. The expression of Sry is among these primary sex-determining functions of the chromosomes, and is the most important of the primary factors. However, Sry is not the only or the earliest of the primary sexdetermining factors, and there are probably numerous others.
Defining primary sex-determining genes and genomic regions The sex of a cell, tissue, or individual is defined by consistent phenotypic differences between males versus females. The emergent phenotype of the tissue is the result of the aggregate effects of complex interconnected molecular networks whose nodes are gene products that drive the expression of each other in the tissue. Sex differences in the network arise when specific gene products are more active in one sex than in the other, driving the expression pattern in one sex away from that in the other [6] . The sex-biased genes are usually autosomal, because most of the genome is autosomal. These autosomal genes, however, cannot be primary in determining the sexual phenotype of the animal, because of the equal representation of autosomal genes in the genome of male and female zygotes. Rather, sex differences in autosomal gene expression must be downstream of the primary sex differences in the expression of X or Y factors that result from the inherent sex difference in the number and type of sex chromosomes. Thus, explaining sex determination requires finding the primary sex chromosome sex-determining genes and the downstream pathways that mediate their effects. Some sex differences in the expression of X genes result from the difference in the number of X chromosomes, but others do not because they are downstream of sex differences in the expression of other genes (e.g. if they are caused by differences in the level of gonadal hormones). Thus, sex differences in the expression of some X genes and all Y genes are inherent products of the imbalance in the sex chromosomes and, therefore, are primary in the determination of the sex of the individual. Note that 'primary' here does not mean 'most important', because the Sry-initiated differentiation of the gonads is most important (because of its widespread downstream effects) among the primary sex-determining genes defined in this way.
Although most primary sex-determining genes or factors have not yet been identified, they fall into one of several classes [7, 8] (Figure 1 ). Class I comprises Y genes, which are expressed only in males and, thus, can have only The sex of the individual can be defined in different ways, giving rise to different conceptual frameworks about what determines sex. Lillie [5] wrote in 1939: 'It is clear that we must make a radical distinction between sex determination and sex differentiation. In most cases the factors of sex determination are chromosomal and subject to the laws of Mendelian inheritance. . .[In] higher vertebrates, the mechanism of sex differentiation is taken over by the extracellular agents, the male and female hormones; but it is necessary to postulate that the endocrine cells producing them are first determined by the nuclear mechanism.' Lillie's dichotomy between 'sex determination' and 'sexual differentiation' still persists because 'sex determination' is usually defined as the differentiation of the gonads (e.g. [68] ). Lillie's distinction appears to stem from the ideas that sexual differentiation of the gonads precedes, and is mechanistically different from, the sexual differentiation of nongonadal cells, and that the sex-defining characteristics of the individual are determined by gonadal secretions. From this viewpoint, a person with a vagina and uterus (i.e. has the potential to bear children) is clearly a female, and a person with a penis is male, even if other important sex-typical traits are discordant with the sex of the individual thus defined (e.g. a male unable to produce sperm is still considered a male). Some sex-typical traits are therefore defined out of sex determination, and sex-specific expression of Xist or of genes causing sex differences in blastocysts seem to have nothing to do with sex determination or with the classic sexdefining traits.
The perspective offered here is that this approach is ultimately unnecessarily constraining because the two sexes typically differ in many tissues and phenotypes, each of which can be considered to contribute to the overall sex of the individual. If 'every cell has a sex' [69] , meaning that XX and XY cells of many types show consistent differences, it makes sense to recognize a diverse set of primary factors (each present in the zygote) that initiate molecular cascades that bias the sexual phenotype of the cells that comprise the individual. Defining of the sex of the individual is not just a semantic exercise, but leads to a conceptual framework for categorizing and studying sex-determining factors (and their interactions) that could cause or reduce sex differences in cells and individuals. male-determining effects. Unless a Y gene is totally redundant with non-Y genes in function so that it has no malespecific effect, it qualifies as a primary sex-determining gene. Sry is the prime example of Class I, but mice with Sry but not other Y genes are not fully male, because they cannot make sperm. Several Y genes are required for normal spermatogenesis [9] [10] [11] and, thus, qualify as primary male-determining genes. Other Y genes probably have other male-determining functions.
Class II sex-determining genes are X genes that are expressed at higher levels in females than in males by virtue of the 2:1 sex ratio in the number of X chromosomes. In the blastocyst, prior to onset of X-inactivation, many or most X genes appear to fall into this class. At this stage, many X genes are expressed at higher levels in females than in males, and these genes probably cause the sex differences in expression found in a large number of autosomal genes at that stage [12] [13] [14] . Although the higher expression of most X genes at this stage could have longlasting sex-specific effects on development and function, the differences are considerably reduced by the onset of X inactivation. The main effect of the silencing of one X chromosome in each non-germline cell of females is to reduce the sex differences in the expression of X genes, so that the degree of sexual dimorphism in X gene expression in adults is globally similar to that found in autosomal genes on a tissue-by-tissue basis [15] . Even after X inactivation has occurred, however, some X genes continue to be expressed from both X chromosomes. Such 'escapees' from inactivation are not necessarily expressed at a higher level in females than in males, however, because other regulatory forces can make their expression more or less equivalent in the two sexes [16, 17] . For example, most of the genes escaping X inactivation in humans, as shown in studies of cell lines in vitro, do not appear to be expressed at higher levels in females [15, 16, 18] . Nevertheless, some X escapees are reliably expressed at higher levels in females than in males, and these genes comprise Class II throughout most of the life of the individual [19] [20] [21] [22] .
Class III genes are X genes that receive a parental imprint. X genes with a maternal imprint function under that constraint potentially in all male cells but only in approximately half of female cells because of inactivation of the maternal X in the other half; by contrast, the effect of a paternal imprint on X genes will occur in approximately half of female cells but never in a male cell. The sex differences in the effect of the imprint could cause sexual differentiation. The parental imprint on X genes is known to influence adult cognitive and social behaviors [23] .
Other mechanisms have been proposed to explain sex differences caused by the imbalance in the number of X chromosomes [8, [24] [25] [26] (Box 2). Recently, evidence has emerged for Class IV sex chromosome factors, which are sex-specific regions of heterochromatin that exert effects on the epigenetic status of the rest of the genome [27, 28] . In Drosophila melanogaster, the Y chromosome contains large regions of heterochromatin, which alter the epigenetic balance of heterochromatin-euchromatin at autosomal loci, and regulate the expression of hundreds to thousands of autosomal and X genes [27, 29, 30] . The Y effect occurs even when no Y protein-coding genes are expressed. One proposed mechanism for such sex-specific regulation is that the sex chromosome heterochromatin can alter the balance of factors (DNA methyl transferases, histone-modifying enzymes, etc.) that change the epigenetic status of chromatin, serving as a sink for factors favoring heterochromatin [27] [28] [29] [30] [31] . The mammalian Y chromosome is also predominantly heterochromatic, but represents a much smaller proportion of the genome than in Drosophila. In mammals, however, each female cell contains an entire heterochromatic X chromosome, which could similarly alter the epigenetic status genome-wide. The production of this relatively large piece of heterochromatin is initiated . is illustrated here] that act as sex-specific sinks for factors (red dots) that regulate the amount of euchromatin and/or heterochromatin at interphase and, therefore, affect gene expression throughout the genome. To date, specific members of only Class I have been identified (Sry and spermatogenesis genes [9] [10] [11] ). Although evidence indicates that the number of X chromosomes leads to some sex differences in phenotype [49] , the specific genes or chromosome regions that explain these X effects have not yet been identified. Class IV is particularly speculative at present because it is based on a limited number of studies. Future studies are likely to expand the importance of Classes II-IV.
TRENDS in Genetics
Box 2. The environment as a source of sex-specific information
In addition to the primary sex determinants encoded by the sex chromosomes, the environment represents an important source of sex-specific information. From the time of birth, males and females are placed in different physical and social environments. Human males and females are taught different social attitudes so that they choose different environments throughout life. The effect of the environment is profound and contributes to sex differences in a wide variety of biological phenotypes, including aging, diet, obesity, behavior and disease. Because the epigenetic mechanisms by which environments alter biological pathways are being investigated with greater frequency [35] , the time may be ripe to investigate the sexspecific factors in the environment that affect the sexual phenotype of individuals. The same epigenetic mechanisms (DNA methylation, histone modifications, etc.) that are influenced by sex-specific factors on the sex chromosomes and by gonadal hormones [34, 35] are also sensitive to sex differences in the environment. Thus, the epigenome may be seen as an integrator of these sex-specific influences. However, very little is known about this integration. by the X-linked factors that activate expression of Xist, which must be considered as a possible primary sex-determining mechanism in mammals. Although little evidence bears on this issue, recent evidence resonates with this concept. Mice differing in the number of X chromosomes show differences in the expression of an autosomal gene that is sensitive to nearby heterochromatic status [28, 31] . Mice with two X chromosomes show greater expression (less autosomal heterochromatin) than do mice with one X chromosome, and the presence of the Y chromosome appears not to affect expression. Moreover, the genome of embryonic stem cells with two X chromosomes is hypomethylated relative to those with one X chromosome, and the cells show reduced expression of the de novo DNA methyltransferases Dnmt3a and Dnmt3b [32] . Dnmt3a, Dnmt3b and other histone modifiers are also found to be expressed differently in male and female blastocysts, which also show differences in DNA methylation [12, 33] . Thus, the heterochromatic inactive X chromosome is proposed to sequester factors regulating the epigenetic status throughout the genome in a sex-specific manner [31] . Several sex-specific processes may converge to alter the phenotype via common epigenetic pathways and the modification of gene expression patterns. In addition to the possible role of Class IV factors, some Class II X genes encode histone demethylases (e.g. Kdm5c and Kdm6a), and are expressed differently in XX and XY mice irrespective of their gonadal sex [20, 21] . These genes are candidate primary sex-determining genes that could affect gene expression throughout the genome. In addition, gonadal secretions during fetal or neonatal life cause permanent sex differences in histone modifications or DNA methylation in brain regions that correlate with the sexual differentiation of function caused by these hormones in specific brain regions [34, 35] . Thus, both primary sex chromosome factors and downstream hormonal factors may have convergent effects that cause long-lasting epigenetic changes that create a sexual bias in the function of tissues (Box 2).
Is Xist a primary sex-determining gene? As defined here, Xist and the X factors that trigger its expression are primary sex-determining genes because: (i) the sex specificity of expression stems directly from the zygotic sexual imbalance in the number of X chromosomes; and (ii) Xist expression makes each non-germline female cell different from each male cell. Yet, the role of Xist is usually seen as the opposite: to reduce sex differences rather than to produce them. The expression of Xist makes X gene expression in females globally more comparable to that of males than would otherwise be the case [15] . This example underscores the idea that the two sexes can reach the same phenotype via different routes, or that sexual equality of phenotype does not imply equality of mechanisms or development. The existence of multiple sex-determining mechanisms means that different pathways can either be synergistic (both promoting the same male or female phenotype) or antagonistic (two sex-specific mechanisms in one sex offsetting the effects of the other) [36] . Xist initiates female-specific mechanisms that reduce the sex-specific effect of another female-specific condition, which is the presence of two X chromosomes. Although female and male cells are differentiated by the expression of the sex-determining gene Xist, some end phenotypes regulated indirectly by Xist are not necessarily made sexually dimorphic.
Despite the major role of Xist in the reduction of sex differences in the expression of X genes, there may be uninvestigated effects of X inactivation that create sex differences in the adult phenotype. Among the possibilities are the proposed effects of Class IV X heterochromatin on the sequestration of factors regulating the epigenetic status of the rest of the genome. More generally, the initiation and maintenance of X inactivation is a highly regulated process, requiring mechanisms that direct the inactivation machinery to only one chromosome in the cell even if other chromosomes are nearby [37] . It seems unlikely that the commitment of resources of female cells to a complex inactivation process would leave the rest of the cell untouched and equivalent to a male cell. Female cells continue throughout life to commit resources to maintaining the inactive status of one X chromosome and preventing this inactivity from having deleterious effects on other chromosomal domains. This burden can be seen as sex determining because it is absent in males. Because the presence of two X chromosomes renders females more susceptible to some diseases [24, 26] , it is possible that this susceptibility is the result of the required commitment to X inactivation [26] .
Sex differences in phenotypes not downstream of gonadal differentiation
What sex differences in phenotypes are influenced by sex chromosome complement irrespective of the sex of the gonads? Two types of evidence are relevant. In some cases, the sex difference appears in embryos before the development of gonads and, hence, cannot be downstream of the switch controlled by Sry. Alternatively, the difference can be shown to depend on the complement of sex chromosomes in an experimental design in which the effects of sex chromosome complement are dissociated from the effects of the gonad.
Sex differences before gonads
The Tammar wallaby represents an early and iconic example of data that clearly conflict with the gonad-centric theory [38] . In this species, the scrotum and mammary tissue begin to differentiate prior to gonadal differentiation. The differentiation of the scrotum versus pouch and mammary glands is controlled by the number of X chromosomes, not by gonadal hormones. Thus, sex chromosome complement controls important aspects of genital differentiation.
In various mammalian species, male embryos are larger than female embryos at numerous specific time points after fertilization, including before implantation [12, 39] . In mice, the sex difference is produced by primary sex-determining genes on both sex chromosomes, including one or more imprinted X genes [39] [40] [41] . Embryos also differ in their glucose metabolism and sensitivity to glucose [12, 42] . Widespread sex differences in the expression of genes have been documented prior to differentiation of the gonads [12] [13] [14] 43] .
Opinion
When cells from rodent midbrain are harvested from day 14 embryos (i.e. before the gonads are producing strikingly different levels of gonadal hormones), the cells show sex differences in vitro, for example in their expression of tyrosine hydroxylase, the rate-limited enzyme for the synthesis of dopamine [44] . These differences are also found in cells harvested from XX versus XY mice irrespective of the type of gonad in the embryos and, hence, are downstream of sex-determining genes other than Sry [45] .
Sex differences caused by sex chromosome complement, dissociated from gonadal effects Several mouse models have been developed that allow the sex-determining role of sex chromosome complement (XX versus XY) to be measured under conditions in which gonadal hormones do not explain the sex differences. Among the informative models are mice or rats in which Sry gene expression is manipulated in non-gonadal tissues [46, 47] , gonadless XX and XY mice (because of knock out of Sf1) [48] , and the 'four core genotypes' (FCG) mouse model, in which the sex of the gonads is independent of the complement of sex chromosomes. In FCG mice, Sry is 'moved' from the Y chromosome and inserted onto an autosome so that the autosome is testis determining [7, 49] . This model allows differences to be discovered in XX and XY mice of the same gonadal sex (called 'sex chromosome effects'), which are examples of sex differences downstream of non-Sry X or Y genes. The model also allows sex differences to be discovered downstream of the switch controlled by Sry (by comparing mice with ovaries and testes that have the same complement of sex chromosomes) [50] , as well as the interaction of Sry and sex chromosome effects. The advantages and caveats for use of various models have been discussed elsewhere [7, 48, 49, 51, 52] .
Sex chromosome complement contributes to sex differences in a wide variety of neural and behavioral phenotypes, including distribution of vasopressin fibers in the lateral septum [7, 53] , brain region-specific expression of nitric oxide synthase, calbindin and prodynorphin [54] [55] [56] , and neural expression of several Class II X genes, including two histone demethylases [20, 21, 57] . In the case of prodynorphin, its higher expression in XX mice relative to XY mice is caused by X genes (Classes II-IV) [56] . XX and XY mice differ in aggressive and parenting behavior [53] , response to noxious stimuli [58] , social and investigation behaviors [50, 59, 60] , and formation of habits in models of drug addiction and alcohol abuse [61, 62] . Sry is expressed in the midbrain substantia nigra, the origin of dopamine neurons that are targets for Parkinson's disease. Knockdown of Sry in the brain of adult males causes reversible male-specific effects on expression of tyrosine hydroxylase and motor behavior, providing the first identification of a Y gene that has direct male-specific effects on the brain that are not mediated by gonadal hormones [46] .
Mouse models of disease (e.g. neural tube closure, autoimmune disease, viral infections and hypertension) have been used to evaluate the contribution of sex chromosome complement to sex differences in physiology or response to disease. Anterior neural tube closure defects occur more often in human females than in males, a sex difference mimicked in mice with a null mutation of Trp53. The sex difference is caused by the number of X chromosomes, not by gonadal sex [26] . Autoimmune diseases, such as multiple sclerosis and systemic lupus erythematosus, affect women more than men. In mouse models of these diseases investigated with FCG mice, XX mice were more affected than XY mice, irrespective of their type of gonad [63] . XX mice also showed greater myocarditis in response to infection with coxsackie virus [64] . In studies of both autoimmune disease and viral infection, the greater immunological response in XX mice correlated with striking XX versus XY differences in the immune system markers. By contrast, hypertension occurs more in men than in women. In studies of rodents, the sex difference is explained in part by gonadal hormones and partly by sex chromosome complement. Chronic or acute treatment of FCG mice with angiotensin II causes different changes in blood pressure and heart rate in XX versus XY mice [65, 66] . In the FCG model, such XX versus XY differences are not explained by effects of Sry. Sry itself is also proposed as a regulator of hypertension via effects on the renin-angiotensin system and sympathetic nervous system [67] . Sry is expressed in non-gonadal tissues of males and its overexpression in adrenal or kidney causes
Box 3. Primary sex-determining factors in birds and other species
The framework proposed here is applicable with minor modifications to any group with heteromorphic sex chromosomes, such as birds (sex chromosomes ZZ male, ZW female). Indeed, research on birds has helped catalyze the increased appreciation of vertebrate sex differences that are not caused by gonadal hormones [8, 70] . A critical difference between birds and mammals is that birds lack a chromosome-wide dosage compensation mechanism akin to Xinactivation, so that the majority of Z genes are expressed at higher levels in males than in females [15, 71, 72] . That difference places a large number of Class II primary sex-determining factors within each male and female cell, which are available for selection as primary causes of sexual dimorphism. Although a large group of studies of birds documents the profound effects of gonadal hormones that cause sex differences in birds [73] , other studies suggest that sex differences are also controlled by sex chromosome effects [74] . For example, the sex of the neural circuit controlling song in zebra finches is not masculinized by testicular tissue in genetic females, and manipulations of gonadal hormones convincingly fail to control the sex of the circuit [74] . In lateral avian gynandromorphs, in which ZZ and ZW cells are present in the same individual and are in the same gonadal endocrine environment, the cells retain some of their sex differences [1, 70] . Importantly, the critical sex-determining role of sex chromosome genes within somatic cells is strongly supported by experiments in which cells from chick embryos of one sex are transplanted into the other, showing that the sexual phenotype of somatic gonadal cells reflects the genetic sex of the donor rather than of the host [1] . The apparently greater influence in birds (versus mammals) of sex chromosome factors, not regulated downstream of gonadal hormones, correlates with the lack of chromosome-wide dosage compensation that leaves many more Z genes in Class II in birds, relative to the situation in mammals, in which Xist reduces the number of Class II sex determinants.
The present conceptual framework can be abstracted and extended to species that lack sex chromosomes. The central task in any explanation of sex determination is to specify all of the primary factors (primary because they are independent of each other at the outset, prior to the start of sex determination) that initiate sex-specific development, and to explain the downstream molecular cascades controlled by the primary factors that lead to sex differences in phenotype.
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Trends in Genetics February 2012, Vol. 28, No. 2 an increase in blood pressure [47] . In cell systems, Sry can regulate the promoter activity of tyrosine hydroxylase and genes in the renin-angiotensin network. Thus, more than one primary sex-determining factor influences sex differences in hypertension.
Concluding remarks and future perspectives
The model proposed here seeks to provide a modern conceptual framework for understanding the sex determination of mammals, although the same framework is applicable to any species with heteromorphic sex chromosomes (Box 3). Because not all biological sex differences are downstream from the differentiation of gonads, the sex of the individual is no longer defined exclusively by the sex of the gonads but rather by the aggregate sexual phenotype of cells and tissues. Rather than recognizing (genetic) gonadal sexual differentiation as mechanistically distinct from (hormonal) sexual differentiation of non-gonadal tissues, the factors determining the sex of all tissues are treated in the same framework. The emphasis is shifted from gonadal differentiation as the central event of sex determination, to the zygotic difference in sex chromosome complement as the primary event. Thus, any factor that has a sex-specific action, because of its unequal representation in male versus female zygotes, is seen as a primary sex-determining factor. Based on current knowledge, the only factors that are inherently unequal in male versus female zygotes are the sex chromosomes, so that all primary sex determinants are X or Y linked. Four major classes of primary sex-determining factors are recognized, although this list may be incomplete. Within this framework, the relative importance, in different tissues or taxa, of different classes of primary sex-determining factors can be recognized. The primary sex-determining factors include Sry, but each is logically primary because of its unequal representation in the male and female genome. This framework recognizes the effect of Sry and downstream sex differences in gonadal hormones as the dominant pathway for sex determination of most nongonadal tissues, but at the same time recognizes multiple primary sex-determining factors not downstream of the gonadal effects of Sry, which act in parallel with gonadal differentiation to influence the sex of tissues, including sex differences in the susceptibility to disease. Xist is unique as a sex-determining gene because it is expressed in most non-germline cells of females. Importantly, the multiple parallel pathways can interact with each other synergistically, to sum their sex-determining effects, or antagonistically, to reduce the sex differences that each would cause by itself.
The challenge for the future is to discover all of the sexdetermining factors on the sex chromosomes, and explain the pathways downstream of each, to understand what makes males and females different. This is not just a theoretical question, but one of potential significance in medicine. The incidence and progression of many diseases differs in males and females, such that one sex is protected from the disease. In some cases, the protection offered by sex-specific factors is greater than that currently afforded by any existing treatment. One strategy for improving treatment of disease is to develop better understanding of the sex-specific regulation of physiology and disease, and to uncover potent protective mechanisms that could be targets for novel therapeutic interventions.
